← FDA Drug Approvals (Drugs@FDA)

IVERMECTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-03-21

Drug application

FDA Application #

ANDA212485

Application type

Abbreviated New Drug Application (Generic)

Brand name

IVERMECTIN

Generic name

Ivermectin

Active ingredients

IVERMECTIN

Dosage form

LOTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2022-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown